Boston, MA -- When it comes to reducing inflammation to decrease the risk of heart disease and stroke, results from the much-anticipated Cardiovascular Inflammation Reduction Trial (CIRT) indicate ...
This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...
Between 1986 and 2003, 43 eligible patients were identified, 29 female and 14 male, ranging in age from 32 years to 88 years at the time of diagnosis. The majority of patients were aged between 50 and ...
High-dose methotrexate (HD-MTX) is administered as prophylaxis for central nervous system (CNS) relapse in Diffuse Large B Cell Lymphoma (DLBCL). It is traditionally administered in an inpatient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results